MICRODELETION SYNDROME 5Q14.3-MEF2C

The microdeletion syndrome 5q14.3-MEF2C Association has beenfounded by families of children affected by this rare disease in order to raise funds for future research and treatment.
This syndrome is based on the lack of a gene or part of a gene on chromosome 5. Specifically, children of this association have the MEF2C gene affected . This Disease affects psychomotor development causing a significant delay with autism spectrum traits and epileptic seizures. There are only about 60 cases diagnosed worldwide with this rare disease.
There is now a research team at the University of California, San Diego (UCSD), led by Dr. Stuart Lipton, who is developing possible treatments for this disease. Dr. Lipton and his group have thrown themselves into this investigation which is in an advanced stage. However, it needs funding to move forward and to treat our children one day in a near future.

I feel the urgency in developing a treatment for our children, probably quite similar to your own feelingsStuart Lipton


Last News

WE ARE ALREADY ON INSTAGRAM!

As you know, in addition to our main goal which is getting treatment for our children, we also have... read more

INTERVIEW WITH JESES, CELIA’S DAD, IN COPE CASTELLÓN

This morning Jesus, Celia's father, had the opportunity to speak about our association and its objectives in Cope (radio... read more

THE SCINTILLON INSTITUTE DEDICATES ITS END-OF-YEAR NEWSLETTER TO OUR CAUSE

Today it ends 2016 , a year that has been a turning point in our lives, and especially in... read more